Patents Examined by Michael Astarino
  • Patent number: 6045501
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: April 4, 2000
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams